These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12732873)

  • 1. Gene- and cell-based therapeutics for type I diabetes mellitus.
    Bottino R; Lemarchand P; Trucco M; Giannoukakis N
    Gene Ther; 2003 May; 10(10):875-89. PubMed ID: 12732873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
    Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
    Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.
    Giannoukakis N; Pietropaolo M; Trucco M
    Diabetes Nutr Metab; 2002 Jun; 15(3):173-203. PubMed ID: 12173733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
    Giannoukakis N; Pietropaolo M; Trucco M
    Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IDDM treatment with an insulin-expressing vector].
    Takeuchi T
    Nihon Rinsho; 2001 Nov; 59(11):2261-7. PubMed ID: 11712417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes.
    Sanlioglu AD; Griffith TS; Omer A; Dirice E; Sari R; Altunbas HA; Balci MK; Sanlioglu S
    J Cell Biochem; 2008 Jun; 104(3):710-20. PubMed ID: 18247339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.
    Chang Y; Yap S; Ge X; Piganelli J; Bertera S; Giannokakis N; Mathews C; Prud'homme G; Trucco M
    Gene Ther; 2005 Dec; 12(23):1679-85. PubMed ID: 16107864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for type 1 diabetes: a proposal to move to the next level.
    Giannoukakis N; Trucco M
    Curr Opin Mol Ther; 2005 Oct; 7(5):467-75. PubMed ID: 16248282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.
    Machen J; Bertera S; Chang Y; Bottino R; Balamurugan AN; Robbins PD; Trucco M; Giannoukakis N
    Gene Ther; 2004 Oct; 11(20):1506-14. PubMed ID: 15229635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J; Sun J; Sung RS
    Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting pancreatic beta-cells.
    Pileggi A; Fenjves ES; Klein D; Ricordi C; Pastori RL
    IUBMB Life; 2004 Jul; 56(7):387-94. PubMed ID: 15545215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modalities and future prospects of gene therapy in heart transplantation.
    Vassalli G; Roehrich ME; Vogt P; Pedrazzini GB; Siclari F; Moccetti T; von Segesser LK
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1036-44. PubMed ID: 19318274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylaxis of autoimmune diabetes by antigen based immune modulation: are we there yet?
    Bot A; von Herrath M
    Minerva Med; 2004 Apr; 95(2):105-14. PubMed ID: 15272245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
    Casu A; Trucco M; Pietropaolo M
    Pediatr Clin North Am; 2005 Dec; 52(6):1779-804. PubMed ID: 16301093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.